Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet for Hypercalcemia in Parathyroid Carcinoma or Intractable PHPT
NCT01460030Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Nov 2011
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cinacalcet in parathyroid carcinoma, primary hyperparathyroidism (PHPT), sponsored by Kyowa Kirin. Started Nov 2011; status: completed.
02
Drugs
cinacalcet
03
Conditions
parathyroid carcinomaprimary hyperparathyroidism (PHPT)
Beyond the preview
Go deeper on NCT01460030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01460030.